Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.

Published

Journal Article

The objective of this study was to evaluate the relationship of amyloid burden, as assessed by florbetapir F 18 ((18)F-AV-45) amyloid positron emission tomography, and cognition in healthy older control (HC) subjects. Seventy-eight HC subjects were assessed with a brief cognitive test battery and positron emission tomography (PET) imaging with (18)F-AV-45. A standard uptake value ratio was computed for mean data from 6 cortical regions using a whole cerebellum reference region. Scans were also visually rated as amyloid positive or amyloid negative by 3 readers. Higher standard uptake value ratio correlated with lower immediate memory (r = -0.33; p = 0.003) and delayed recall scores (r = -0.25; p = 0.027). Performance on immediate recall was also lower in the visually rated amyloid positive compared with amyloid negative HC (p = 0.04), with a similar trend observed in delayed recall (p = 0.06). These findings support the hypothesis that higher amyloid burden is associated with lower memory performance among clinically normal older subjects. Longitudinal follow-up is ongoing to determine whether (18)F-AV-45 may also predict subsequent cognitive decline.

Full Text

Duke Authors

Cited Authors

  • Sperling, RA; Johnson, KA; Doraiswamy, PM; Reiman, EM; Fleisher, AS; Sabbagh, MN; Sadowsky, CH; Carpenter, A; Davis, MD; Lu, M; Flitter, M; Joshi, AD; Clark, CM; Grundman, M; Mintun, MA; Skovronsky, DM; Pontecorvo, MJ; AV45-A05 Study Group,

Published Date

  • March 2013

Published In

Volume / Issue

  • 34 / 3

Start / End Page

  • 822 - 831

PubMed ID

  • 22878163

Pubmed Central ID

  • 22878163

Electronic International Standard Serial Number (EISSN)

  • 1558-1497

Digital Object Identifier (DOI)

  • 10.1016/j.neurobiolaging.2012.06.014

Language

  • eng

Conference Location

  • United States